Core Points - The core viewpoint of the article is that Sinovac Biotech (科兴制药) has successfully completed a share transfer inquiry, with a determined price of 30.88 yuan per share and full subscription of the offered shares by institutional investors [2] Group 1 - Sinovac Biotech announced the inquiry transfer price of 30.88 yuan per share based on the subscription situation as of September 15, 2025 [2] - A total of 21 institutional investors participated in the bidding and subscription, with a combined effective subscription of 10,190,000 shares, resulting in an effective subscription multiple of 1.01 times [2] - The total number of shares to be transferred has been fully subscribed, with the preliminary determined transferees being 21 institutional investors, who will acquire a total of 10,062,800 shares [2]
科兴制药:股东询价转让初步定价为30.88元/股